Clinical Trials Browser

Phase 2 × Leukemia × AEG 35156 × Clear all

NCT01018069 2011-07-13

AEG35156 in Combination With High-dose Cytarabine and Idarubicin in AML Following Failure of a Single Standard Dose Cytarabine Based Frontline Induction Regimen

Phase 2 Terminated

Other hematologic neoplasm

Leukemia, Leukemia, Promyelocytic, Acute